DNA Methylation of Tumor-Suppressor miRNA Genes in Chronic Lymphocytic Leukemia

References

• Chiorazzi N , RaiKR , FerrariniM . Chronic lymphocytic leukemia . N. Engl. J. Med.352 , 804 – 815 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Crespo M , BoschF , VillamorNet al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia . N. Engl. J. Med.348 , 1764 – 1775 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Oscier DG , GardinerAC , MouldSJet al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors . Blood100 , 1177 – 1184 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Hamblin TJ , DavisZ , GardinerA , OscierDG , StevensonFK . Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia . Blood94 , 1848 – 1854 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Kröber A , SeilerT , BennerAet al. VH mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia . Blood100 , 1410 – 1416 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Haferlach C , DickerF , SchnittgerS , KernW , HaferlachT . Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgVH status and immunophenotyping . Leukemia21 , 2442 – 2451 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Döhner H , StilgenbauerS , BennerAet al. Genomic aberrations and survival in chronic lymphocytic leukemia . N. Engl. J. Med.343 , 1910 – 1916 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Munk Pedersen I , ReedJ . Microenvironmental interactions and survival of CLL B-cells . Leuk. Lymphoma45 , 2365 – 2372 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F , BertilaccioM , ScielzoC . How the microenvironment wires the natural history of chronic lymphocytic leukemia . Semin. Cancer Biol.24 , 43 – 48 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Longo PG , LaurentiL , GobessiS , SicaS , LeoneG , EfremovDG . The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells . Blood111 , 846 – 855 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Pleyer L , EgleA , HartmannTN , GreilR . Molecular and cellular mechanisms of CLL: novel therapeutic approaches . Nat. Rev. Clin. Oncol.6 , 405 – 418 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Lu D , ZhaoY , TawataoRet al. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia . Proc. Natl Acad. Sci. USA101 , 3118 – 3123 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Furman RR , AsgaryZ , MascarenhasJO , LiouH-C , SchattnerEJ . Modulation of NF-κB activity and apoptosis in chronic lymphocytic leukemia B cells . J. Immunol.164 , 2200 – 2206 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Cuni S , Perez-AciegoP , Perez-ChaconGet al. A sustained activation of PI3K/NF-κB pathway is critical for the survival of chronic lymphocytic leukemia B cells . Leukemia18 , 1391 – 1400 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Puente XS , PinyolM , QuesadaVet al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia . Nature475 , 101 – 105 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Quesada V , CondeL , VillamorNet al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia . Nature Genet.44 , 47 – 52 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Fabbri G , RasiS , RossiDet al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation . J. Exp. Med.208 , 1389 – 1401 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Wang L , LawrenceMS , WanYet al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia . N. Engl. J. Med.365 , 2497 – 2506 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Kulis M , HeathS , BibikovaMet al. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia . Nature Genet.44 , 1236 – 1242 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Chim CS , LiangR , KwongYL . Hypermethylation of gene promoters in hematological neoplasia . Hematol. Oncol.20 , 167 – 176 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Jones PA . Cancer: death and methylation . Nature409 , 141 – 144 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Robertson KD . DNA methylation and human disease . Nat. Rev. Genet.6 , 597 – 610 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Esteller M . Epigenetics in cancer . N. Engl. J. Med.358 , 1148 – 1159 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Jones PA , BaylinSB . The epigenomics of cancer . Cell128 , 683 – 692 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Portela A , EstellerM . Epigenetic modifications and human disease . Nat. Biotechnol.28 , 1057 – 1068 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Laird PW . Cancer epigenetics . Hum. Mol. Genet.14 , R65 – R76 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Knudson AG . Karnofsky Memorial Lecture. Hereditary cancer: theme and variations . J. Clin. Oncol.15 , 3280 – 3287 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Thiagalingam S , FoyRL , ChengK-H , LeeHJ , ThiagalingamA , PonteJF . Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence . Curr. Opin. Oncol.14 , 65 – 72 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Vousden KH , LuX . Live or let die: the cell’s response to p53 . Nat. Rev. Cancer2 , 594 – 604 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Yue Z , JinS , YangC , LevineAJ , HeintzN . Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor . Proc. Natl Acad. Sci. USA100 , 15077 – 15082 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Berger AH , KnudsonAG , PandolfiPP . A continuum model for tumour suppression . Nature476 , 163 – 169 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Esteller M . Epigenetic gene silencing in cancer: the DNA hypermethylome . Hum. Mol. Genet.16 , R50 – R59 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Chim CS , FungTK , WongKF , LauJS , LawM , LiangR . Methylation of INK4 and CIP/KIP families of cyclin-dependent kinase inhibitor in chronic lymphocytic leukaemia in Chinese patients . J. Clin. Pathol.59 , 921 – 926 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Chim CS , PangR , FungTK , ChoiCL , LiangR . Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma . Leukemia21 , 2527 – 2536 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Chim CS , FungTK , CheungWC , LiangR , KwongYL . SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway . Blood103 , 4630 – 4635 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Gonzalez-Zulueta M , BenderCM , YangASet al. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing . Cancer Res.55 , 4531 – 4535 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Raval A , TannerSM , ByrdJCet al. Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia . Cell129 , 879 – 890 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Chen SS , ClausR , LucasDMet al. Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL . Blood117 , 862 – 871 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Chim CS , FungTK , WongK , LauJ , LiangR . Frequent DAP kinase but not p14 or Apaf-1 hypermethylation in B-cell chronic lymphocytic leukemia . J. Hum. Genet.51 , 832 – 838 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Chim CS , PangR , LiangR . Epigenetic dysregulation of the Wnt signalling pathway in chronic lymphocytic leukaemia . J. Clin. Pathol.61 , 1214 – 1219 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Bartel DP . MicroRNAs: target recognition and regulatory functions . Cell136 , 215 – 233 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Bartel DP . MicroRNAs: genomics, biogenesis, mechanism, and function . Cell116 , 281 – 297 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Calin GA , SevignaniC , DumitruCDet al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers . Proc. Natl Acad. Sci. USA101 , 2999 – 3004 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Croce CM . Causes and consequences of microRNA dysregulation in cancer . Nat. Rev. Genet.10 , 704 – 714 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Chen C-Z . MicroRNAs as oncogenes and tumor suppressors . N. Engl. J. Med.353 , 1768 – 1771 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Calin GA , DumitruCD , ShimizuMet al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia . Proc. Natl. Acad. Sci. USA99 , 15524 – 15529 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Cimmino A , CalinG , FabbriMet al. miR-15 and miR-16 induce apoptosis by targeting BCL2 . Proc. Natl Acad. Sci. USA102 , 13944 – 13949 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Klein U , LiaM , CrespoMet al. The DLEU2/miR-15a/16–1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia . Cancer Cell17 , 28 – 40 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Pekarsky Y , PalamarchukA , MaximovVet al. Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL . Proc. Natl Acad. Sci. USA105 , 19643 – 19648 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Bichi R , ShintonSA , MartinESet al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression . Proc. Natl Acad. Sci. USA99 , 6955 – 6960 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Pekarsky Y , SantanamU , CimminoAet al. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181 . Cancer Res.66 , 11590 – 11593 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Calin GA , FerracinM , CimminoAet al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia . N. Engl. J. Med.353 , 1793 – 1801 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Santanam U , ZanesiN , EfanovAet al. Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression . Proc. Natl Acad. Sci. USA107 , 12210 – 12215 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Visone R , VeroneseA , RassentiLZet al. miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia . Blood118 , 3072 – 3079 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Zhu D-X , ZhuW , FangCet al. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes . Carcinogenesis33 , 1294 – 1301 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Calin GA , CimminoA , FabbriMet al. MiR-15a and miR-16–1 cluster functions in human leukemia . Proc. Natl Acad. Sci. USA105 , 5166 – 5171 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Fabbri M , BottoniA , ShimizuMet al. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia . JAMA305 , 59 – 67 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Li S , MoffettHF , LuJet al. MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells . PLoS ONE6 , e16956 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Calin G , LiuC , SevignaniCet al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias . Proc. Natl Acad. Sci. USA101 , 11755 – 11760 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Fulci V , ChiarettiS , GoldoniMet al. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia . Blood109 , 4944 – 4951 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Visone R , RassentiLZ , VeroneseAet al. Karyotype-specific microRNA signature in chronic lymphocytic leukemia . Blood114 , 3872 – 3879 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Wang LQ , LiangR , ChimCS . Methylation of tumor suppressor microRNAs: lessons from lymphoid malignancies . Expert Rev. Mol. Diagn.12 , 10 ( 2012 ).
   Web of Science ®Google Scholar
• Pallasch CP , PatzM , ParkYJet al. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia . Blood114 , 3255 – 3264 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Baer C , ClausR , FrenzelLPet al. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia . Cancer Res.72 , 3775 – 3785 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Saini S , MajidS , ShahryariVet al. miRNA-708 control of CD44+ prostate cancer-initiating cells . Cancer Res.72 , 3618 – 3630 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Chen SS , RavalA , JohnsonAJet al. Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia . Proc. Natl Acad. Sci. USA106 , 13433 – 13438 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Hermeking H . The miR-34 family in cancer and apoptosis . Cell Death Differ.17 , 193 – 199 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Yamakuchi M , LowensteinCJ . MiR-34, SIRT1 and p53 . Cell Cycle8 , 712 – 715 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Zenz T , EichhorstB , BuschRet al. TP53 mutation and survival in chronic lymphocytic leukemia . J. Clin. Oncol.28 , 4473 – 4479 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Lujambio A , CalinGA , VillanuevaAet al. A microRNA DNA methylation signature for human cancer metastasis . Proc. Natl Acad. Sci. USA105 , 13556 – 13561 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Gallardo E , NavarroA , ViñolasNet al. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer . Carcinogenesis30 , 1903 – 1909 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Wong KY , YuL , ChimCS . DNA methylation of tumor suppressor miRNA genes: a lesson from the miR-34 family . Epigenomics3 , 83 – 92 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Vogt M , MundingJ , GrünerMet al. Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas . Virchows Arch.458 , 313 – 322 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Lodygin D , TarasovV , EpanchintsevAet al. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer . Cell Cycle7 , 2591 – 2600 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Chim CS , WongKY , QiYet al. Epigenetic inactivation of the miR-34a in hematological malignancies . Carcinogenesis31 , 745 – 750 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Toyota M , SuzukiH , SasakiYet al. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer . Cancer Res.68 , 4123 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Tsai KW , WuCW , HuLYet al. Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer . Int. J. Cancer129 , 2600 – 2610 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Corney DC , HwangCI , MatosoAet al. Frequent downregulation of miR-34 family in human ovarian cancers . Clin. Cancer Res.16 , 1119 – 1128 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Wang LQ , KwongYL , WongKFet al. Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia . J. Transl. Med.12 , 52 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Cardinaud B , MoreilhonC , MarcetBet al. miR-34b/miR-34c: a regulator of TCL1 expression in 11q- chronic lymphocytic leukaemia . Leukemia23 , 2174 – 2177 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Pigazzi M , ManaraE , BaronE , BassoG . miR-34b targets cyclic AMP–responsive element binding protein in acute myeloid leukemia . Cancer Res.69 , 2471 – 2478 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Wong KY , LiangR , SoCC , JinDY , CostelloJF , ChimCS . Epigenetic silencing of MIR203 in multiple myeloma . Br. J. Haematol.154 , 569 – 578 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Deneberg S , KanduriM , AliDet al. microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemia . Epigenetics9 , 0 – 1 ( 2014 ).
   Web of Science ®Google Scholar
• Ma L , YoungJ , PrabhalaHet al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis . Nat. Cell Biol.12 , 247 – 256 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Tsai KW , LiaoYL , WuCWet al. Aberrant hypermethylation of miR-9 genes in gastric cancer . Epigenetics6 , 1189 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Schraivogel D , WeinmannL , BeierDet al. CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells . EMBO J.30 , 4309 – 4322 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Nass D , RosenwaldS , MeiriEet al. MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors . Brain Pathol.19 , 375 – 383 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Heller G , WeinzierlM , NollCet al. Genome-wide miRNA expression profiling identifies miR-9–3 and miR-193a as targets for DNA methylation in non-small cell lung cancers . Clin. Cancer Res.18 , 1619 – 1629 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Zhang H , QiM , LiSet al. microRNA-9 targets matrix metalloproteinase 14 to inhibit invasion, metastasis, and angiogenesis of neuroblastoma cells . Mol. Cancer Ther.11 , 1454 – 1466 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Guo LM , PuY , HanZet al. MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-κB1 . FEBS J.276 , 5537 – 5546 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Wang LQ , KwongYL , KhoCSBet al. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia-implications on constitutive activation of NFκB pathway . Mol. Cancer12 , 173 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Anderlind C , SpiraA , CardosoWV , LüJ . miR-129 regulates cell proliferation by downregulating Cdk6 expression . Cell Cycle9 , 1809 – 1818 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Bandres E , AgirreX , BitarteNet al. Epigenetic regulation of microRNA expression in colorectal cancer . Int. J. Cancer125 , 2737 – 2743 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Huang Y , LiuJ , DeatherageDet al. Epigenetic repression of microRNA-129–2 leads to overexpression of SOX4 oncogene in endometrial cancer . Cancer Res.69 , 9038 – 9046 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Wong KY , YimRLH , KwongYLet al. Epigenetic inactivation of the MIR129–2 in hematological malignancies . J. Hematol. Oncol.6 , 16 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Agirre X , Vilas-ZornozaA , Jimenez-VelascoAet al. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia . Cancer Res.69 , 4443 – 4453 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Furuta M , KozakiK-I , TanakaS , AriiS , ImotoI , InazawaJ . miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma . Carcinogenesis31 , 766 – 776 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Wilting SM , Van BoerdonkRaA , HenkenFEet al. Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer . Mol. Cancer9 , 167 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Silber J , LimDA , PetritschCet al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells . BMC Med.6 , 14 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Xia J , WuZ , YuCet al. miR-124 inhibits cell proliferation in gastric cancer through down-regulation of SPHK1 . J. Pathol.227 , 470 – 480 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Wang P , ChenL , ZhangJet al. Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1 . Oncogene33 , 514 – 524 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Wong KY , SoCC , LoongFet al. Epigenetic inactivation of the miR-124–1 in haematological malignancies . PLoS ONE6 , e19027 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Bueno MJ , Pérez De CastroI , Gómez De CedrónMet al. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression . Cancer Cell13 , 496 – 506 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Chim CS , WongKY , LeungCYet al. Epigenetic inactivation of the hsa-miR-203 in haematological malignancies . J. Cell Mol. Med.15 , 2760 – 2767 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Stamatopoulos B , MeulemanN , Haibe-KainsBet al. microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification . Blood113 , 5237 – 5245 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Esteller M , Sanchez-CespedesM , RosellR , SidranskyD , BaylinSB , HermanJG . Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients . Cancer Res.59 , 67 – 70 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Mori T , O’DaySJ , UmetaniNet al. Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy . J. Clin. Oncol.23 , 9351 – 9358 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Zhang YJ , WuHC , ShenJet al. Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA . Clin. Cancer Res.13 , 2378 – 2384 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Blum KA , LiuZ , LucasDMet al. Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylation . Br. J. Haematol.150 , 189 – 195 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Prensner JR , ChinnaiyanAM . The emergence of lncRNAs in cancer biology . Cancer Discov.1 , 391 – 407 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Mercer TR , DingerME , MattickJS . Long non-coding RNAs: insights into functions . Nat. Rev. Genet.10 , 155 – 159 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Esteller M . Non-coding RNAs in human disease . Nat. Rev. Genet.12 , 861 – 874 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Lee K-H , LottermanC , KarikariCet al. Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer . Pancreatology9 , 293 – 301 ( 2009 ).
   PubMed Web of Science ®Google Scholar